Interventional device developer Boston Scientific said that the U.S. Food and Drug Administration approved the Natick, MA-based firm's Latitude 2.0 patient monitoring software with remote data integration capabilities.
The application is a remote monitoring system for managing patients with heart failure and patients at risk of sudden cardiac death, Boston Scientific said. Latitude 2.0 also provides clinicians with direct device-data integration capabilities into the Centricity electronic medical record (EMR) system from GE Healthcare of Chalfont St. Giles, U.K.
The companies said that the capability to collect patient data remotely using Latitude 2.0 technology and integrating that information within the patient's EMR will enable physicians to make better decisions at the point of care.
By AuntMinnie.com staff writers
November 9, 2006
Related Reading
Road to RSNA, GE Healthcare, November 9, 2006
Road to RSNA, GE Healthcare, November 8, 2006
Road to RSNA, GE Healthcare, November 7, 2006
Road to RSNA, GE Healthcare, November 6, 2006
Boston to bring Liberte to Japan, November 6, 2006
Copyright © 2006 AuntMinnie.com